|
|
Suppliers for
Daunorubicinol hydrochloride
|
|
1 Registered suppliers
Description : Daunorubicinol Hydrochloride is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. - Molecular Weight :566.00
- Melting Point :> 173°C (dec.)
- Purity :≥95%
Molecular Formula : C27H32ClNO10 Canonical SMILES : Cl.O=C1C=2C=CC=C(OC)C2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(CC4OC5OC(C)C(O)C(N)C5)C(O)C InChI : InChI=1S/C27H31NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10-11,14,16-17,22,29-30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,11-,14-,16-,17-,22+,27-;/m0./s1 InChIKey : LQLMJJJLWJUAMM-VSTLEVLBSA-N Solubility : Soluble in DMSO (Slightly), Methanol (Slightly) Appearance : Orange-red Needles Storage : Store at -20°C Synonyms : 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, hydrochloride, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin Hydrochloride; Duborimycin Hydrochloride; Leukaemomycin D Hydrochloride; L-lyxo-Hexopyranoside, 1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-, hydrochloride, (1S,3S)-α-; 13-Dihydrodaunomycin hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, hydrochloride (1:1), (8S,10S)-; Antibiotic RP 20798; Antibiotic 20798 RP; Dihydrodaunomycin hydrochloride; NSC 180510
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-06-20
|